Vaxcyte Appoints Whitney Jones as Chief People Officer
— Ms. Jones Joins Vaxcyte With Over 20 Years of Experience Leading People and Culture Strategies Across Multiple Industries —
SAN CARLOS, Calif., Jan. 16, 2024 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq:PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced the appointment of Whitney Jones as Chief People Officer. Ms. Jones will lead Vaxcyte’s human resources strategy and operations, including people and culture, talent acquisition and management, learning and development, total rewards and employee engagement.
Related news for (PCVX)
- Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
- Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
- Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
- Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
- Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants